United States securities and exchange commission logo





                          July 8, 2020

       Pamela Haley
       Chief Financial Officer
       Arcadia Biosciences, Inc.
       202 Cousteau Place, Suite 105
       Davis, CA 95618

                                                        Re: Arcadia
Biosciences, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed July 2, 2020
                                                            File No. 333-239641

       Dear Ms. Haley:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Deanna
Virginio at 202-551-4530 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Michael De Angelis,
Esq.